The EUDAMED 2026 deadline is no longer something to plan around – it is something to act on now. For manufacturers, authorised representatives, and distributors of medical devices and IVDs operating in the EU, the May deadline marks the point at which full EUDAMED obligations become enforceable across all relevant modules. With the 60 days before EUDAMED now in view, the window for unhurried preparation has closed.
This article covers what still needs to happen, where the most common gaps appear, and how to move through the final days of EUDAMED deadline pressure without costly errors.
What the May 2026 Date Actually Enforces
The mandatory date of EUDAMED in 2026 brings full enforceability to obligations that have been phased in over the preceding years. This is not a new system going live – it is an existing system for which the grace period ends.
The European Commission’s EUDAMED portal and its module-specific guidance make clear that actor registration, device registration, UDI assignment, and certificate linkage are all within scope. Organisations that still have gaps in any of these areas are not dealing with a paperwork issue – they are dealing with a market access risk.
For organisations still working through last minute EUDAMED compliance steps, the most important thing to understand is that enforcement is member-state-led.
National competent authorities use EUDAMED as their primary reference for compliance checks, and a device without a complete and accurate registration has no reliable regulatory standing.
What Still Needs to Happen in the Next 60 Days
Most organisations at this stage have gaps in at least one of four areas: actor registration, device and UDI data, certificate linkage, or QMS alignment.
- Actor registration – Your SRN (Single Registration Number) needs to be active and verified, and your legal entity details need to match what your national authority has on file. For non-EU manufacturers, your Authorised Representative (EAR) also needs to be correctly linked in EUDAMED – not just named in your paperwork. If that link is missing or wrong, the regulatory standing of your devices can be called into question.
- Device and UDI data – Your UDI-DI entries need to be registered and connected to the certificate module, and a Technical File Review should confirm that your documentation matches what’s in EUDAMED.
- Worth a specific mention here: GMDN and EMDN codes are wrong more often than expected. The EMDN is the EU-specific nomenclature required under MDR/IVDR, and if the code is outdated, too broad, or doesn’t match your CE certificate scope, registration will fail.
- Certificate linkage – Certificates from a notified body need to be registered and linked in EUDAMED – and with NB capacity still stretched across the EU, any certificate still in progress is a risk as May approaches. The Medical Device Coordination Group’s guidance documents do cover transitional provisions for specific situations, but they are not a workaround for a missing certificate.
- QMS alignment – Your Quality Management System needs to have clear ownership of EUDAMED data maintenance built into it: not just the initial registration, but ongoing updates, incident reporting, and field safety notices. Treating EUDAMED as a one-time setup task rather than a standing QMS obligation is a pattern that shows up repeatedly in post-deadline audit findings.
IVDR Has Its Own Pressure Points
Many IVDs that sat in a lower risk category under the old IVD Directive have moved up under IVDR Annex VIII rules, bringing notified body involvement into scope for the first time. If a device has been reclassified and the Notified Body Application process is still running, that is a direct timeline risk for May – not something to monitor, but something to actively manage.
Performance evaluation documentation for IVDs also needs to align with EUDAMED device records, and this works differently from MDR clinical evaluation requirements. The European Commission’s medical devices regulation overview covers transition timelines by device class in full, and it is worth checking your devices against it if there is any uncertainty about where they sit.
Other Areas Worth Checking Before May
Two further obligations are worth confirming before the deadline arrives. Interruption of Supply Notification obligations in EUDAMED apply to devices classified as critical – competent authorities monitor supply continuity through the database, and the notification pathway needs to be documented and tested, not just acknowledged.
On the legal side, a Legal Services review is worth undertaking if contractual arrangements between manufacturer and EAR have not been revisited recently, or if GDPR considerations around data submitted to EUDAMED have not been formally addressed.
A Quick Checklist for the Final Stretch
If you want a single reference for the EU MDR IVDR deadline checklist at 60 days out, these are the areas to confirm:
Actor and entity: SRN active and verified, EAR appointed and correctly linked for non-EU manufacturers, legal entity details consistent with national authority records.
Device and UDI: Basic UDI-DI registered, EMDN/GMDN codes verified, device classification reviewed, technical file consistent with EUDAMED records.
Certificates: CE or IVDR certificates registered and linked in EUDAMED, certificate scope matching device records, NB timeline confirmed.
Post-market: Serious incident and FSCA reporting pathways established, supply notification obligations confirmed where applicable.
QMS and governance: Internal responsibility for EUDAMED maintenance assigned, data accuracy reviewed, procedures documented.If any of these are incomplete, the final days of the EUDAMED deadline call for targeted action, not further planning.
Getting Ready with Obelis
Obelis handles the full range of what the EUDAMED May 2026 deadline countdown demands – from EUDAMED Registration support across actor, device, and certificate modules, to Authorised Representative (EAR) services for non-EU manufacturers, Technical File Review, CE Marking Guidance, and Quality Management System Support aligned with ongoing EUDAMED maintenance.
If the legal side needs attention, Legal Services covering EAR contracts and GDPR considerations are part of the offer too. For organisations that need a broader strategic review, Consultancy for Medical Devices covers the full picture.
Reaching the team is straightforward – schedule a call directly on the Obelis website and the conversation starts from where you actually are.
FAQs
Missing the EUDAMED mandatory date in 2026 does not trigger automatic market withdrawal everywhere simultaneously-but it leaves your devices without verified regulatory standing in the system authorities rely on.
This creates real risks: reduced market access, audit exposure, and loss of credibility, especially when operating across multiple EU countries where issues can spread between jurisdictions.
IVDR reclassifies many devices into higher risk categories requiring notified body involvement, and its performance evaluation data feeds into EUDAMED differently from MDR clinical data. As a result, MDR and IVDR compliance processes are not interchangeable.
These codes are mandatory and validated against certificates. Errors-like mismatched codes, wrong specificity, or misalignment with CE scope-lead to registration failures or inconsistencies flagged by authorities.
Without a certificate, full EUDAMED registration isn’t possible. Options include pushing the notified body for timelines, checking transitional or derogation routes, and assessing commercial risk-often requiring specialist consultancy.
Leave a Reply